Imexpharm Corporation
Sector: Manufacturing
Industry: Chemical - Pharmaceutical

Open
High
Low
Vol
Market Cap.
Remain Bid
Remain Ask
52Wk High
52Wk Low
52Wk Avg Vol
Foreign Buy
Frgn Owned(%)
Dividend
Dividend Yield
Beta
EPS
P/E
F P/E
BVPS
P/B
1 day | 5 days | 3 months | 6 months | 12 months
 
 
Overview
 
Profile
 
Trading Data
 
Technical Analysis
 
Financials
 
News & Events
 
Documents
 
Compare
 
History price
DatePriceChangeVolumeAvg. BuyAvg. SellForeign BuyForeign Sell
21/02/25 48,500 -750(-1.52%) 188,700717.871,326.7321,4009,000
20/02/25 49,250 +1,250(2.60%) 213,7001,014.47958.4930,10016,000
19/02/25 48,000 -850(-1.74%) 564,700777.421,125.8418,90049,332
18/02/25 48,850 +50(0.10%) 137,900735.47933.591,20022,200
17/02/25 48,800 +700(1.46%) 526,5001,084.61,038.7668,50016,210
Financials
Industry Peers
  News
IMP: Change in personnel
IMP: Mephydica no longer being an associated company
IMP: Change in personnel
IMP: Resolution of General Meeting of Shareholders
IMP: Minutes of voting checking result
IMP: Materials on collecting shareholders' opinions written
IMP: Change in personnel
  Download documents
   IMP: Corporate Governance Report 2024
   IMP: FS Quarter 4 of 2024
   IMP: FS Quarter 3 of 2024
   IMP: Regulations 2024
   IMP: Explanation for FS the first 6 month of 2024
  Overview
Contact Listing Inf. Business Reg. Additional Inf. Events Notes
Exchange HoSE
Sector Manufacturing
Industry Chemical - Pharmaceutical
Listing date 12/04/2006
Chartered capital 1,540,427,620,000
Shares listed 154,042,762
Shares outstanding 154,008,962